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Dendritic Cells: Antigen Presenting Cells of T and B Lymphocytes
Cl-322 PRIMARY IMMUNE RESPONSE INDUCTION
BY DKNDR1TIC CELLS
C¡ill Marlanei, Alexander B. 11. Bakker, Richard J. F. Huijbenx, Coxxe J. 
Adema and Carl C. Fif’dor, Department of Tumor Immunology, University 
llospitul Nijmegen, Nijinegcn, The Netherlands
Recently, we and others have identified antigens recognizcd by anti- 
melanoma cytotoxic T cells (CTL). These tumor-associated antigens 
provide potential targets for immunotherapy against melanoma. A key 
question is how immune responses against these antigens can be induced 
most efficiently. The potent antigen presentation capacity of dcndritic cclls 
renders them suitable for exploitation in the induction of these responses, 
Wc investigated the capacity of dendritic ccils obtained from heulthy donors 
to induce CTL responses against peptides derived from the niclanocyte 
differentiation antigens gplQG, tyrosinase or melun-A/Mart-1. For these 
purposes dcndritic cells were generated by culturing highly enriched 
monocytes, obtained bv centrifugal elutriation, in the presence of GM-CSF 
and 1L-4 as dcscribcd by Romani et id. (1994), When pulsed with pep! ides
derived from the aforementioned antigens, lhaxo cclls were able to induce u 
primary CTL response in vitro, Furthermore these CTL were capable of 
lysing melanoma cclls, indicating that they recognized peptides derived 
from the melanoma differentiation antigens. These data demonstrate that 
CTL reactivc with melanocyte differentiation antigens can be induced in 
healthy donors vising dendritic ceils.
While the powerful antigen presentation capacity of dendritic cells 
has been well documented* the mechanisms by which this is achieved have 
yet to be elucidated, We have employed the technique of differential display 
PCI? in an attempt to identify novel proteins which are specific to dendritic 
cclls and thus muy account for the functional properties of these cclls. This 
method allows for the selection of mRNAs which are differentially 
expressed in different cell types. Dcndritic cell RNA, from nl least three 
healthy donors, was compared to RNA from a panel of inonocytc, B cell 
and T cell lines. Using multiple primer sets, numerous PCR products have 
been identified which appear to he specific to dendritic cclls. 
Characterization of these cDNAs is ongoing and may provide insights into 
the role of dendritic celts in the induction of primary immune responses.
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